InvestSMART

Cambium Bio Limited (ASX: CMB) - Announcements

Current share price for CMB : $0.500 0.005 (1.01%)+

ASX company news and announcements for Cambium Bio Limited (CMB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cambium Bio Limited (CMB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cambium Bio Limited (CMB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cambium Bio Limited (CMB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 Results of General Meeting 16 Mar 2026 1:23PM $0.480 $0.500 risen by 4.17%
$15 Half Year Report and Accounts 20 Feb 2026 9:39AM $0.525 $0.500 fallen by 4.76%
$15 Proposed issue of securities - CMB 11 Feb 2026 10:52AM $0.570 $0.500 fallen by 12.28%
$15 Notice of General Meeting/Proxy Form 11 Feb 2026 10:52AM $0.570 $0.500 fallen by 12.28%
$15 Quarterly Activities/Appendix 4C Cash Flow Report 23 Jan 2026 9:14AM $0.550 $0.500 fallen by 9.09%
$15 Proposed issue of securities - CMB 20 Jan 2026 8:19AM $0.460 $0.500 risen by 8.70%
$15 Cambium Bio Secures A$2.4 Million Strategic Investment 20 Jan 2026 8:19AM $0.460 $0.500 risen by 8.70%
$15 Quarterly Activities/Appendix 4C Cash Flow Report 27 Oct 2025 3:50PM $0.485 $0.500 risen by 3.09%
$15 Corrective Appendix 3Y Terrence Walts 27 Oct 2025 3:20PM $0.485 $0.500 risen by 3.09%
$15 Change of Directors Interest Notice - TW 24 Oct 2025 8:18AM $0.480 $0.500 risen by 4.17%
$15 Change of Directors Interest Notice - EW 24 Oct 2025 8:18AM $0.480 $0.500 risen by 4.17%
$15 Amended Constitution 17 Oct 2025 10:26AM $0.460 $0.500 risen by 8.70%
$15 Cleansing notice 16 Oct 2025 4:09PM $0.460 $0.500 risen by 8.70%
$15 Notification regarding unquoted securities - CMB 16 Oct 2025 3:56PM $0.460 $0.500 risen by 8.70%
$15 Application for quotation of securities - CMB 16 Oct 2025 3:54PM $0.460 $0.500 risen by 8.70%
$15 Results of Annual General Meeting 16 Oct 2025 3:09PM $0.460 $0.500 risen by 8.70%
$15 Cambium AGM CEO address 16 Oct 2025 10:33AM $0.460 $0.500 risen by 8.70%
$15 Cambium Bio Signs Manufacturing MOU with Locus Cell 30 Sep 2025 1:32PM $0.520 $0.500 fallen by 3.85%
$15 Proposed issue of securities - CMB 15 Sep 2025 10:31AM $0.510 $0.500 fallen by 1.96%
$15 Notice of Annual General Meeting and Proxy form 15 Sep 2025 10:27AM $0.510 $0.500 fallen by 1.96%
$15 Cambium Bio Signs Strategic MoU with Benta SAS 5 Sep 2025 11:37AM $0.465 $0.500 risen by 7.53%
$15 Cambium Bio Signs US$2.0M plus Licensing Deal 2 Sep 2025 1:07PM $0.465 $0.500 risen by 7.53%
$15 FY25 Appendix 4G and Corporate Governance Statement 29 Aug 2025 4:00PM $0.470 $0.500 risen by 6.38%
$15 FY25 Appendix 4E and Annual Report 29 Aug 2025 3:56PM $0.470 $0.500 risen by 6.38%
$15 FY25 Appendix 4E and Annual Report 29 Aug 2025 3:56PM $0.470 $0.500 risen by 6.38%

26 - 50 of 138 results

Page 2 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.